InsideArbitrage Event Driven Monitor – March 28, 2023

Quick updates on the event driven strategies we follow on InsideArbitrage.

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. Jounce Therapeutics (JNCE) to be acquired by Concentra Biosciences for -$123.48 million or $1.85 per share in cash plus a non-tradeable contingent value right .
2. CVS Health (CVS) announced that it expects to complete its acquisition of Signify Health (SGFY) on or around March 29, 2023.
3. ARKO Corp. (ARKO) issued a letter urging Travel Centers of America’s (TA) Board to seriously consider ARKO’s proposal to acquire TravelCenters and engage with, rather than exclude, ARKO in the sale process.

Only plus or premium subscribers can access this post. Subscribe today.